Whole-body lifetime occupational lead exposure and risk of Parkinson's disease
- PMID: 17185278
- PMCID: PMC1764163
- DOI: 10.1289/ehp.9102
Whole-body lifetime occupational lead exposure and risk of Parkinson's disease
Abstract
Background: Several epidemiologic studies have suggested an association between Parkinson's disease (PD) and exposure to heavy metals using subjective exposure measurements.
Objectives: We investigated the association between objective chronic occupational lead exposure and the risk of PD.
Methods: We enrolled 121 PD patients and 414 age, sex, and race, frequency-matched controls in a case-control study. As an indicator of chronic Pb exposure, we measured concentrations of tibial and calcaneal bone Pb stores using 109Cadmium excited K-series X-ray fluorescence. As an indicator of recent exposure, we measured blood Pb concentration. We collected occupational data on participants from 18 years of age until the age at enrollment, and an industrial hygienist determined the duration and intensity of environmental Pb exposure. We employed physiologically based pharmacokinetic modeling to combine these data, and we estimated wholebody lifetime Pb exposures for each individual. Logistic regression analysis produced estimates of PD risk by quartile of lifetime Pb exposure.
Results: Risk of PD was elevated by > 2-fold [odds ratio = 2.27 (95% confidence interval, 1.13-4.55); p = 0.021] for individuals in the highest quartile for lifetime lead exposure relative to the lowest quartile, adjusting for age, sex, race, smoking history, and coffee and alcohol consumption. The associated risk of PD for the second and third quartiles were elevated but not statistically significant at the alpha = 0.05 level.
Conclusions: These results provide an objective measure of chronic Pb exposure and confirm our earlier findings that occupational exposure to Pb is a risk factor for PD.
Figures
References
-
- American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC:American Psychiatric Association.
-
- Anthony JC, LeResche L, Niaz U, von Korff MR, Folstein MF. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397–408. - PubMed
-
- Aquilonius SM, Hartvig P. A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand. 1986;74:379–382. - PubMed
-
- Bevington PR. 1969. Data Reduction and Error Analysis for the Physical Sciences. New York:McGraw-Hill.
-
- Bradbury MW, Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology. 1993;14:131–136. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
